Robust IB & trading revenues and lower interest rates are likely to aid HSBC's fourth-quarter results. Yet, high costs are ...

Accropeutics Inc. (Accropeutics), a clinical-stage biotechnology company pioneering the development of novel therapeutics that target molecular mechanisms of regulated cell death for immune mediated ...